Review Article
Management Strategy Change of Endometrial Hyperplasia
2Department of Obstetrics & Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
Received Date: July 24, 2018; Published Date: August 20, 2018
Abstract
Endometrial hyperplasia refers to irregular proliferation of endometrial glands, combined with an increased proportion of gland and mesenchyme. This kind of disease generally results from reproductive endocrine disorder, which is closely related to long-term estrogen stimulation without progesterone antagonism. In recent years, the views on the treatment and management of endometrial hyperplasia have been updated and changed with the deepening of research. This paper mainly focuses on the following aspects: classification change of endometrial hyperplasia, indication change of diagnostic curettage, management change of endometrial hyperplasia.
Keywords: Endometrial hyperplasia; Diagnostic curettage; Levonorgestrel-releasing intrauterine system; Management strategy
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
